Symposium:
131. Managing Non-ID Co-Morbidities in HIV-Infected Patients
Friday, October 4, 2013: 2:00 PM-3:30 PM
Room: The Moscone Center: 135 (Hall E)

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • identify new approaches to addressing central nervous system issues in HIV-infected patients
  • apply new techniques for preventing and managing cardiovascular disease with HIV patients
  • describe hot topics in managing osteoporosis and hypogonadism

Target Audience: researchers, members-in-training, infectious diseases physicians, HIV specialists, HIV clinicians, fellows, clinicians

Tracks: HIV-STD-TB

Moderator:  Joel Gallant, MD, MPH, FIDSA, Southwest Care Center

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: No CPE credit is offered for this session.

ACPE Number:

Disclosures:

J. Gallant, Gilead Sciences: Investigator and Scientific Advisor, Consulting fee and Research grant
Bristol-Myers Squibb: Scientific Advisor, Consulting fee
Merck & Co.: Scientific Advisor, Consulting fee
Janssen Therapeutics: Scientific Advisor, Consulting fee
Takara Bio, Inc.: Scientific Advisor, Consulting fee

C. Marra, None

P. Hsue, Gilead: Scientific Advisor, Speaker honorarium

T. Brown, Gilead: Consultant, Consulting fee
ViiV Healthcare: Scientific Advisor, Consulting fee
BMS: Scientific Advisor, Consulting fee
Merck: Grant Investigator and Scientific Advisor, Consulting fee and Research grant
EMD-Serono: Scientific Advisor, Consulting fee

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.